LeadIQ logo
Learn more at LeadIQ.com
✕

Access Insights for Carmot Therapeutics, Inc. and Millions of Other Companies

Sign up for full access to Carmot Therapeutics, Inc. information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Insights

Loading spinner
Gathering insights about Carmot Therapeutics, Inc.…

Similar companies to Carmot Therapeutics, Inc.

✕

Access Insights for Carmot Therapeutics, Inc. and Millions of Other Companies

Sign up for full access to Carmot Therapeutics, Inc. information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Carmot Therapeutics, Inc. Tech Stack

Carmot Therapeutics, Inc. uses 8 technology products and services including Cloudflare, Google Font API, Twitter Emoji (Twemoji), and more. Explore Carmot Therapeutics, Inc.'s tech stack below.

  • Cloudflare
    Content Management System
  • Google Font API
    Font Scripts
  • Twitter Emoji (Twemoji)
    Font Scripts
  • Open Graph
    Miscellaneous
  • RSS
    Miscellaneous
  • Yoast SEO
    Search Engines
  • Jetpack
    Web Platform Extensions
  • Nginx
    Web Servers

Media & News

Carmot Therapeutics, Inc.'s Email Address Formats

Carmot Therapeutics, Inc. uses at least 2 format(s):
Carmot Therapeutics, Inc. Email FormatsExamplePercentage
FLast@carmot.usJDoe@carmot.us
55%
First.Last@carmot.usJohn.Doe@carmot.us
45%

Frequently Asked Questions

Where is Carmot Therapeutics, Inc.'s headquarters located?

Minus sign iconPlus sign iconCarmot Therapeutics, Inc.'s main headquarters is located at Berkeley, US. The company has employees across 2 continents, including North AmericaEurope.

What is Carmot Therapeutics, Inc.'s stock symbol?

Minus sign iconPlus sign iconCarmot Therapeutics, Inc. is a publicly traded company; the company's stock symbol is CRMO.

What is Carmot Therapeutics, Inc.'s official website and social media links?

Minus sign iconPlus sign iconCarmot Therapeutics, Inc.'s official website is carmot-therapeutics.us and has social profiles on LinkedIn.

How much revenue does Carmot Therapeutics, Inc. generate?

Minus sign iconPlus sign icon As of June 2024, Carmot Therapeutics, Inc.'s annual revenue reached $3.8M.

What is Carmot Therapeutics, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign iconCarmot Therapeutics, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Carmot Therapeutics, Inc. have currently?

Minus sign iconPlus sign iconAs of June 2024, Carmot Therapeutics, Inc. has approximately 57 employees across 2 continents, including North AmericaEurope. Key team members include Chief Executive Officer: H. T.Vice President Clinical Operations: M. E.Head Of Biostatistics, Sr. Dir: J. W.. Explore Carmot Therapeutics, Inc.'s employee directory with LeadIQ.

What industry does Carmot Therapeutics, Inc. belong to?

Minus sign iconPlus sign iconCarmot Therapeutics, Inc. operates in the Biotechnology Research industry.

What technology does Carmot Therapeutics, Inc. use?

Minus sign iconPlus sign iconCarmot Therapeutics, Inc.'s tech stack includes CloudflareGoogle Font APITwitter Emoji (Twemoji)Open GraphRSSYoast SEOJetpackNginx.

What is Carmot Therapeutics, Inc.'s email format?

Minus sign iconPlus sign iconCarmot Therapeutics, Inc.'s email format typically follows the pattern of . Find more Carmot Therapeutics, Inc. email formats with LeadIQ.

How much funding has Carmot Therapeutics, Inc. raised to date?

Minus sign iconPlus sign icon As of June 2024, Carmot Therapeutics, Inc. has raised $150M in funding. The last funding round occurred on May 25, 2023 for $150M.
Carmot Therapeutics, Inc.

Carmot Therapeutics, Inc.

Biotechnology ResearchBerkeley, United States51-200 Employees

Carmot has been acquired by Roche in early 2024, making the company a member of the Roche Group. Carmot Therapeutics is a clinical-stage biotechnology company that is focused on advancing life-changing therapeutics for people with obesity and diabetes. We are utilizing Chemotype Evolution, a pioneering drug discovery platform, to identify novel incretin receptor signaling targets to develop a broad pipeline of therapeutics that have the potential to produce significant weight loss and improved glycemic control. We have three clinical candidates: CT-388, CT-868 and CT-996.

✕

Access Insights for Carmot Therapeutics, Inc. and Millions of Other Companies

Sign up for full access to Carmot Therapeutics, Inc. information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Section iconCompany Overview

Headquarters
Berkeley, US
Website
carmot-therapeutics.us
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
CRMO
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $150M

    Carmot Therapeutics, Inc. has raised a total of $150M of funding over 8 rounds. Their latest funding round was raised on May 25, 2023 in the amount of $150M.

  • $10M

    Carmot Therapeutics, Inc.'s revenue is in the range of $10M

Section iconFunding & Financials

  • $150M

    Carmot Therapeutics, Inc. has raised a total of $150M of funding over 8 rounds. Their latest funding round was raised on May 25, 2023 in the amount of $150M.

  • $10M

    Carmot Therapeutics, Inc.'s revenue is in the range of $10M

Company Leadership

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

✕

Access Insights for Carmot Therapeutics, Inc. and Millions of Other Companies

Sign up for full access to Carmot Therapeutics, Inc. information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.